why choose us

First received: November 9, 2022

Clinical Trial: MEDI5752 in Japanese Patients With Advanced Solid Tumors.

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Advanced Solid Tumors

Study Type: Interventional


Official Title: A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Japanese Subjects With Advanced Solid Tumors

Brief Summary: This is a Phase 1, open-label study evaluate the safety, tolerability, pharmacokinetics, immunogenicity and anti-tumor activity of MEDI5752 in Japanese patients with advanced solid solid tumors.

Read more